Jennifer Eatrides, MD

Cancer Focus:
Anal Cancer, Benign Hematology, Colon Cancer, Colorectal Cancer, Hodgkin Lymphoma, Leukemia, Multiple Myeloma-Plasma Cell Disorders, Non-Hodgkin Lymphoma

Dr. Jennifer Eatrides is a member of the Moffitt Medical Group in the Satellite and Community Oncology Department practicing at Tampa General Hospital and Moffitt international Plaza. Dr. Eatrides earned her MD degree with a research focus at the University of South Florida Morsani College of Medicine. She completed an Internal Medicine Residency and completed a Hematology and Oncology Fellowship at the University of South Florida and Moffitt Cancer Center. Dr. Eatrides has a particular interest in hematologic malignancies. The MMG faculty at TGH provides invaluable medical oncology services to the large patient population of this leading regional hospital.

Education & Training

Fellowship:

• University of South Florida - Hematology and Oncology

Residency:

• University of South Florida - Internal Medicine

Medical School:

• University of South Florida - MD

• Zhang Y, Rose A, Khadka S, Cao B, Eatrides J, Saeed H, Shah BD, Chavez J, Bello C, Lazaryan A, Khimani F, Ibarz JP, Liu HD, Locke FL, Jain MD, Zhang L, Kharfan-Dabaja MA, Kim J, Ayala E, Nishihori T, Sokol L. Autologous Hematopoietic Cell Transplantation Consolidation for First Response is Associated With Longer Survival Among Patients With Nodal Peripheral T Cell Lymphoma. Transplant Cell Ther. 2024 Sep.30(9):887.e1-887.e9. Pubmedid: 38740140.
• Laber DA, Patel PC, Logothetis CN, Patel AK, Jaglal M, Haider M, Visweshwar N, Rajasekaran-Rathnakumar G, Eatrides J. Complement-mediated thrombotic microangiopathy treated with anticomplement protein 5 therapy, a retrospective study. Eur J Haematol. 2024 Mar.112(3):450-457. Pubmedid: 37984551.
• Visweshwar N, Fletcher B, Jaglal M, Laber DA, Patel A, Eatrides J, Rathnakumar GR, Iyer KV, Ayala I, Manoharan A. Impact of Phlebotomy on Quality of Life in Low-Risk Polycythemia Vera. J Clin Med. 2024 Aug.13(16). Pubmedid: 39201091. Pmcid: PMC11355660.
• Jordan A, Jain AG, Koipallil GK, Reddy M, Chakkoli S, Midha S, Phuoc V, Eatrides J, Erhardt C, Patel AK, Rico J, Visweshar N, Mhaskar R, Parikh N, Laber D, Jaglal M. Can we lower the platelet threshold of ≥ 50 × 109/L for performing a lumbar puncture safely in patients with hematological malignancies?. Ann Hematol. 2023 Mar.102(3):663-668. Pubmedid: 36534146.
• Lee D, Jain AG, Deutsch Y, Eatrides J, Chan O, Padron E, Kuykendall A, Komrokji R, Lancet J, Sallman D, Talati C, Sweet K. CPX-351 Yields Similar Response and Survival Outcome in Younger and Older Patients With Secondary Acute Myeloid Leukemia. Clin Lymphoma Myeloma Leuk. 2022 Oct.22(10):774-779. Pubmedid: 35760672.
• Logothetis CN, Patel A, Eatrides J, Jaglal M, Haider M, Visweshwar N, Laber DA. Post Approval Experience with Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura at a Single Institution. J Clin Med. 2021 Jul.10(15). Pubmedid: 34362201. Pmcid: PMC8347784.
• Hernandez JM, Quarles R, Lakshmi S, Casanas B, Eatrides J, McCoy E, Somboonwit C. Pancytopenia and Profound Neutropenia as a Sequela of Severe SARS-CoV-2 Infection (COVID-19) With Concern for Bone Marrow Involvement. Open Forum Infect Dis. 2021 Feb.8(2):ofab017. Pubmedid: 33604404. Pmcid: PMC7880265.
• Laber DA, Eatrides J, Jaglal MV, Haider M, Visweshwar N, Patel A. A phase I/II study of docetaxel in combination with pegylated liposomal doxorubicin in metastatic castration-resistant prostate cancer. Med Oncol. 2020 Sep.37(10):95. Pubmedid: 32979106.
• Eroglu Z, Eatrides J, Naqvi SMH, Kim Y, Rich J, Babacan NA, Brohl AS, Markowitz J, Sarnaik A, Zager J, Khushalani NI, Sondak VK, Messina J. Neoadjuvant BRAF-targeted therapy in regionally advanced and oligometastatic melanoma. Pigment Cell Melanoma Res. 2020 Jan.33(1):86-95. Pubmedid: 31329344. Pmcid: PMC6928428.
• Eatrides J, Thompson Z, Lee JH, Bello C, Dalia S. Serum albumin as a stable predictor of prognosis during initial treatment in patients with diffuse large B cell lymphoma. Ann Hematol. 2015 Feb.94(2):357-358. Pubmedid: 25034876.
• Williams M, Eatrides J, Kim J, Talwar H, Esposito N, Szabunio M, Ismail-Khan R, Kiluk J, Lee M, Laronga C, Khakpour N. Comparison of breast magnetic resonance imaging clinical tumor size with pathologic tumor size in patients status post-neoadjuvant chemotherapy. Am J Surg. 2013 Oct.206(4):567-573. Pubmedid: 23809673.
• Turaga KK, Chau A, Eatrides JM, Kiluk JV, Khakpour N, Laronga C, Lee MC. Selective application of routine preoperative axillary ultrasonography reduces costs for invasive breast cancers. Oncologist. 2012 Jan.16(7):942-948. Pubmedid: 21572122. Pmcid: PMC3228129.
• Lee MC, Eatrides J, Chau A, Han G, Kiluk JV, Khakpour N, Cox CE, Carter WB, Laronga C. Consequences of axillary ultrasound in patients with T2 or greater invasive breast cancers. Ann Surg Oncol. 2011 Jan.18(1):72-77. Pubmedid: 20585876.
• Moser JM, Sassano ER, Leistritz del C, Eatrides JM, Phogat S, Koff W, Drake DR. Optimization of a dendritic cell-based assay for the in vitro priming of naïve human CD4+ T cells. J Immunol Methods. 2010 Feb.353(1-2):8-19. Pubmedid: 19925804.
• Eatrides J, Tucci VT, Schrot R. The Case of the Infection that Wasn't !. J Glob Infect Dis. 2009 Jul.1(2):139-143. Pubmedid: 20300404. Pmcid: PMC2840960.
• Pendyala PR, Ayong L, Eatrides J, Schreiber M, Pham C, Chakrabarti R, Fidock DA, Allen CM, Chakrabarti D. Characterization of a PRL protein tyrosine phosphatase from Plasmodium falciparum. Mol Biochem Parasitol. 2008 Mar.158(1):1-10. Pubmedid: 18096253.
• Eatrides J, Wang E, Kothari N, Kim R. Role of Systemic Therapy and Future Directions for Hepatocellular Carcinoma. Cancer Control. 24(3):1073274817729243. Pubmedid: 28975834. Pmcid: PMC5937243.

Voted top doctor in Hematology/Oncology in Tampa Magazine’s Top Doctors 2025.